Insider Transactions in Q4 2023 at Xeris Biopharma Holdings, Inc. (XERS)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 27
2023
|
Jeffrey W Sherman Director |
BUY
Open market or private purchase
|
Indirect |
5,400
+50.0%
|
$5,400
$1.87 P/Share
|
|
Nov 20
2023
|
Dawn Halkuff Director |
BUY
Open market or private purchase
|
Indirect |
5,410
+50.0%
|
$5,410
$1.84 P/Share
|
|
Nov 20
2023
|
Steven Pieper Officer |
BUY
Open market or private purchase
|
Direct |
28,000
+2.32%
|
$28,000
$1.95 P/Share
|
|
Nov 17
2023
|
John Patrick Shannon Jr Director |
BUY
Open market or private purchase
|
Direct |
30,769
+2.14%
|
$30,769
$1.64 P/Share
|
|
Nov 16
2023
|
John P. Schmid Director |
BUY
Open market or private purchase
|
Indirect |
6,500
+50.0%
|
$6,500
$1.51 P/Share
|
|
Nov 14
2023
|
Marla Persky Director |
BUY
Open market or private purchase
|
Indirect |
6,370
+50.0%
|
$6,370
$1.58 P/Share
|